Cargando…

Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline

Pancreatic cancer is the seventh leading cause of cancer deaths worldwide, accounting for 4.7% of all cancer deaths, and is expected to climb significantly over the next decade. The purpose of this systematic review and guidance document was to synthesize the evidence surrounding the role of adjuvan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biagi, James J., Cosby, Roxanne, Bahl, Mala, Elfiki, Tarek, Goodwin, Rachel, Hallet, Julie, Hirmiz, Khalid, Mahmud, Aamer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378160/ https://www.ncbi.nlm.nih.gov/pubmed/37504342 http://dx.doi.org/10.3390/curroncol30070482

Ejemplares similares

Adjuvant Radiotherapy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis
por: Zalay, Osbert, et al.
Publicado: (2022)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

Resection of isolated liver oligometastatic disease in pancreatic ductal adenocarcinoma: Is there a survival benefit? A systematic review
por: Halle-Smith, James M, et al.
Publicado: (2023)

Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
por: Iyengar, Siddharth, et al.
Publicado: (2021)

Treatment results in patients with ductal carcinoma in situ treated with adjuvant radiotherapy
por: GÜZELÖZ, Zeliha, et al.
Publicado: (2019)

The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer
por: Melosky, Barbara, et al.
Publicado: (2021)

Stereotactic Radiotherapy after Radical Prostatectomy in Patients with Prostate Cancer in the Adjuvant or Salvage Setting: A Systematic Review
por: Schröder, Christina, et al.
Publicado: (2022)

Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
por: Kang, Sora, et al.
Publicado: (2022)

Hypofractionated Radiotherapy for Resectable Pancreatic Ductal Adenocarcinoma: A World First in Response to COVID19
por: Spiers, H.V., et al.
Publicado: (2022)

Meta‐analysis of the impact of neoadjuvant therapy on patterns of recurrence in pancreatic ductal adenocarcinoma
por: Schorn, S., et al.
Publicado: (2018)

Ductal Dilatation of ≥5 mm in Intraductal Papillary Mucinous Neoplasm Should Trigger the Consideration for Pancreatectomy: A Meta-Analysis and Systematic Review of Resected Cases
por: Wu, Y.H. Andrew, et al.
Publicado: (2021)

Prognostic biomarkers related to tumoral microenvironment in pancreatic ductal adenocarcinoma: a systematic review
por: Constantin, Alina Liliana, et al.
Publicado: (2021)

Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Mikolaskova, Iveta, et al.
Publicado: (2023)

Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes
por: Roesel, Raffaello, et al.
Publicado: (2023)

Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma
por: Habermehl, Daniel, et al.
Publicado: (2015)

Resection of unicentric interlobar Castleman disease with following adjuvant radiotherapy
por: Sarana, Bruno, et al.
Publicado: (2017)

Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma
por: Ng, Sylvia S. W., et al.
Publicado: (2022)

Clinical Outcomes of Ductal Carcinoma In Situ of the Breast Treated with Partial Mastectomy without Adjuvant Radiotherapy
por: Hwang, Seung Hyun, et al.
Publicado: (2012)

Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Huerta, Marisol, et al.
Publicado: (2021)

A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments
por: Pérez-Díez, Irene, et al.
Publicado: (2023)

Surveillance versus Adjuvant Treatment with Chemotherapy or Radiotherapy for Stage I Seminoma: A Systematic Review and Meta-Analysis According to EAU COVID-19 Recommendations
por: Kang, Dong Hyuk, et al.
Publicado: (2022)

Clinical outcomes of tissue expanders on adjuvant radiotherapy of resected retroperitoneal sarcoma
por: Yu, Jeong Il, et al.
Publicado: (2016)

Adjuvant intensity-modulated radiotherapy improves outcomes for resected complex keloids
por: Ilori, Evelyn O., et al.
Publicado: (2022)

Immediate and delayed autologous abdominal microvascular flap breast reconstruction in patients receiving adjuvant, neoadjuvant or no radiotherapy: a meta‐analysis of clinical and quality‐of‐life outcomes
por: Khajuria, A., et al.
Publicado: (2019)

Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma
por: Wysocka, Olga, et al.
Publicado: (2016)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
por: Flis, Vojko, et al.
Publicado: (2016)

Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
por: Lekka, Kyriaki, et al.
Publicado: (2019)

Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Bonds, Morgan, et al.
Publicado: (2019)

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023)

Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer
por: Péchoux, Cecile Le, et al.
Publicado: (2013)

Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma
por: Chen, Yi-Dong, et al.
Publicado: (2014)

Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy
por: Kim, Tae Gyu
Publicado: (2017)

Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline
por: Malthaner, Richard A, et al.
Publicado: (2004)

Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network meta-analysis of randomized controlled trials
por: Hu, Qiancheng, et al.
Publicado: (2019)

Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
por: Tempero, Margaret A., et al.
Publicado: (2023)

Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic Review
por: Buwenge, Milly, et al.
Publicado: (2022)

The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases
por: Wu, Linxia, et al.
Publicado: (2022)

Neoadjuvant Stereotactic Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis of the Literature and Ongoing Clinical Trials
por: Palmisciano, Paolo, et al.
Publicado: (2022)

Molecular Signatures in Ductal Carcinoma In Situ (DCIS): A Systematic Review and Meta-Analysis
por: Ouattara, Drissa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d7q1c5t3fpco3um7c7snljmq41